Scholar Rock Holding Corp Income Taxes Disclosure
11. Income Taxes
For the years ended December 31, 2025 and 2024, the loss before income taxes consisted of the following (in thousands):
| For Year Ended | |||||
December 31, | ||||||
| 2025 | | 2024 | |||
Domestic | $ | (377,734) | $ | (246,294) | ||
Foreign |
| (205) |
| — | ||
Total | $ | (377,939) | $ | (246,294) | ||
The Company has not recorded a current tax provision for the years ended December 31, 2025 and 2024.
The effective income tax rate differed from the amount computed by applying the federal statutory rate to the Company’s loss before income taxes as follows (in thousands):
For Year Ended |
| |||||
December 31, |
| |||||
| 2025 | |||||
Tax effected at statutory rate |
| $ | (79,367) | 21.0 | % | |
| — | — | ||||
Foreign tax effects |
|
| ||||
Other foreign jurisdictions | 43 | |||||
Effect of cross border transactions |
| — | — | |||
Enactment of new tax laws |
| — | — | |||
Nontaxable or nondeductible items |
| |||||
Stock compensation |
|
| (7,831) | 2.1 | ||
Limitation on executive compensation |
|
| 8,850 | (2.3) | ||
Other |
| 182 | (0.1) | |||
Tax credits |
| |||||
Research & development credits |
| (3,167) | 0.8 | |||
Orphan drug credits |
|
| (16,047) | 4.3 | ||
Change in valuation allowance | 97,362 | (25.8) | ||||
Change in unrecognized tax benefits | — | — | ||||
| (25) | |||||
| $ | — | — | % | ||
For Year Ended |
| ||
December 31, |
| ||
| 2024 | ||
Tax effected at statutory rate |
| 21.0 | % |
State taxes |
| 5.9 | |
Stock compensation |
| (0.5) | |
Non-deductible expenses |
| (0.3) | |
Federal research and development credits |
| 5.8 | |
Other | (0.8) | ||
Change in valuation allowance |
| (31.1) | |
| — | % |
The amount of cash income taxes paid (net of refunds) during the year are as follows (in thousands):
For Year Ended |
| |||
December 31, |
| |||
| 2025 | |||
Federal |
| $ | — | |
State |
| |||
Massachusetts |
|
| 37 | |
New Hampshire |
| 5 | ||
All other states |
| 4 | ||
Foreign | — | |||
Total |
| $ | 46 |
Deferred tax assets (liabilities) consist of the following at December 31, 2025 and 2024 (in thousands):
| As of | |||||
December 31, | ||||||
| 2025 | | 2024 | |||
Deferred tax assets: | | | ||||
Net operating loss carryforwards | $ | 247,969 | $ | 139,160 | ||
Tax credits |
| 82,317 |
| 61,027 | ||
Capitalized research & development | 64,991 | 80,357 | ||||
Stock based compensation | 13,568 | 8,920 | ||||
Operating lease liability | 2,431 | 3,971 | ||||
Reserve and accruals | 4,623 | 4,139 | ||||
Total gross deferred tax assets |
| 415,899 |
| 297,574 | ||
Valuation allowance |
| (413,017) |
| (293,064) | ||
Total deferred tax assets | 2,882 | 4,510 | ||||
Total deferred tax liabilities: | ||||||
Operating lease right-of-use asset | (2,742) | (4,148) | ||||
Fixed and intangible assets |
| (140) |
| (362) | ||
Total deferred tax liabilities | (2,882) | (4,510) | ||||
Total net deferred tax assets | $ | — | $ | — | ||
Total Net Deferred Tax Assets
Deferred tax assets are reduced by a valuation allowance if, based on the weight of available positive and negative evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Accordingly, a full valuation allowance has been established against the net deferred tax assets as of December 31, 2025 and 2024. The valuation allowance for deferred tax assets increased by $120.0 million and $76.5 million in 2025 and 2024, respectively. This increase mainly relates to the establishment of a valuation allowance against the Company’s net deferred tax assets in connection with net operating losses generated in each year and additional tax credit carryforwards generated. As of December 31, 2025, the Company had approximately $921.9 million and $861.4 million of Federal and State operating loss carryforwards respectively, which begin to expire in 2032, except for $871.4 million of the Company’s federal net operating loss carryforwards, and $3.2 million of state net operating losses that do not expire. These loss carryforwards may be available to reduce future taxable income, if any. These loss carryforwards are subject to review and possible adjustment by the appropriate taxing authorities. As of December 31, 2025, the Company also had federal and state credit carryforwards of $74.1 million and $10.4 million, respectively, which begin to expire in 2034 and 2032, respectively. The amount of loss and credit carryforwards that may be utilized in any future period may be limited based upon changes in the ownership of the Company. Additionally, the deductibility of federal net operating
losses generated after December 31, 2017 and the indefinite state net operating losses is limited to 80% of the Company’s taxable income in any future taxable year.
The Company follows the provisions of ASC 740-10, “Accounting for Uncertainty in Income Taxes,” which specifies how tax benefits for uncertain tax positions are to be recognized, measured, and recorded in financial statements; requires certain disclosures of uncertain tax matters; specifies how reserves for uncertain tax positions should be classified on the balance sheet; and provides transition and interim period guidance, among other provisions. As of December 31, 2025 and 2024, the Company has not recorded any amounts for uncertain tax positions. The Company’s policy is to recognize interest and penalties accrued on any uncertain tax positions as a component of income tax expense, if any, in its statements of income.
The Company’s net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a three-year period in excess of 50 percent as defined under Section 382 and 383 of the U.S. Internal Revenue Code of 1986, respectively, as well as similar state provisions. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. The Company conducted a Section 382 study covering the period of November 26, 2013 through December 31, 2023. The study concluded that ownership changes occurred during that period which limit the amount of the Company’s net operating losses and tax credit carryforwards that can be utilized before expiring. The carryforwards disclosed represent the amount of attributes that can be utilized based on the results of the study.
All of the Company’s tax years will remain open for examination by the federal and state tax authorities to the extent that the Company's tax attributes are utilized in future years to offset income or income taxes.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 3, 2026 | Showing above |
| 2024 | Feb 27, 2025 | |
| 2023 | Mar 19, 2024 | |
| 2022 | Mar 7, 2023 | |
| 2021 | Mar 7, 2022 | |
| 2020 | Mar 9, 2021 | |
| 2019 | Mar 12, 2020 | |
| 2018 | Mar 19, 2019 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.